Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 13/10/23 → 12/10/25 |
Keywords
- Clinical trial
- DCSZ11-101
Clinical Trial Phase
- Phase I
A Phase 1, Multicenter, Open-Label, Dose Escalation, and Dose Expansion Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of DCSZ11 as a Monotherapy in Patients with Advanced or Metastatic Solid Tumors.
- Richardson, Gary (Primary Chief Investigator (PCI))
Project: Research